Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z Song, Y Yu, Z Chen, S Lu - Chinese Medical Journal, 2011 - mednexus.org
Background Several clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.
ZB Song, YF Yu, ZW Chen, S Lu - Chinese Medical Journal, 2011 - europepmc.org
Background Several clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z Song, Y Yu, Z Chen, S Lu - Chinese medical journal, 2011 - pubmed.ncbi.nlm.nih.gov
Background Several clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
[PDF][PDF] Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z SONG, Y YU, Z CHEN, S LU - Chinese Medical Journal, 2011 - researchgate.net
Background Several clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z SONG, Y YU, Z CHEN, S LU - Chinese Medical Journal, 2011 - pesquisa.bvsalud.org
ABSTRACT< p>< b> BACKGROUND</b> Several clinical trials showed that erlotinib was
effective after the failure of gefitinib in advanced non-small cell lung cancer (NSCLC). The …
effective after the failure of gefitinib in advanced non-small cell lung cancer (NSCLC). The …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z SONG, Y YU, Z CHEN, LU Shun - Chinese Medical Journal, 2011 - journals.lww.com
Background Several clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.
Z Song, Y YU, Z Chen, LU Shun - Chinese Medical Journal, 2011 - wprim.whocc.org.cn
BACKGROUNDSeveral clinical trials showed that erlotinib was effective after the failure of
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to …
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment
Z SONG, Y YU, Z CHEN, LU Shun - Chinese Medical Journal, 2011 - pesquisa.bvsalud.org
< p>< b> BACKGROUND</b> Several clinical trials showed that erlotinib was effective after
the failure of gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study …
the failure of gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study …